Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 1997

View Archived Issues

Chugai reports sydnonimine derivatives for angina

Banyu claims farnesyltransferase inhibitors

New antitumor taxanes from Yakult Honsha

German introduction for Parkinsan

GeneMedicine and UCSF enter into gene therapy collaboration

Sparta's Spartaject busulfan enters phase I

Draxis Health completes acquisition of Merck Frosst radiopharmaceutical division

DuPont Merck and Elan enter alliance for copromotion of Parkinson's disease products

Progression of Epix Medical's diagnostic agent to phase II triggers milestone payment

Virus Research Institute's rotavirus vaccine enters phase II

Interleukin-11 reviewed

Generic etodolac approved by FDA

TEI-A0225: new treatment for restenosis

Cardiovascular effects of psychotropic drugs

Magnesium implicated in death from cardiovascular disease

Immunological effects of HMG-CoA reductase inhibitors in humans

n-3 fatty acids for prevention of restenosis

Natural products for hyperlipidemia

ETA receptor blockade for counteracting effects of angiotensin II

Hematopoiesis-stimulating compounds from SmithKine Beecham and Nycomed

SmithKline Beecham describes LTB4 antagonists for psoriasis

Factor Xa inhibitors from Berlex

Paclitaxel derivatives developed at Bristol-Myers Squibb

Phase II/III results for Seroquel

In vitro activity of novel pneumocandin antifungal agent

ReoPro effective in baboon models of human renal disorders

HIV-IG pharmacokinetics assessed in AIDS patients

Pharmacokinetic, drug interaction and clinical results with ziprasidone

Once-daily extended-release venlafaxine evaluated in depression

Roberts seeks European approval of Agrylin

Novavax's Estrasorb reduces hot flashes by up to 98% in postmenopausal women

ALRT reports clinical trial status of Panretin

Cel-Sci developing AIDS vaccine with broad activity

Antithrombotic efficacy of TAK-029 in animal models

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...